Yan Liu

Dr. Yan Liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2020 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
JHJianguang Hu
Jianguang Hu
XZXiaoshi Zhong
Xiaoshi Zhong
JYJing Yan
Jing Yan
DZDaoyuan Zhou
Daoyuan Zhou
DQDanping Qin
Danping Qin
YLYan Liu
Yan Liu
Background: Chronic kidney disease (CKD) disease affects gut flora by causing dysbiosis and lead to systemic inflammatory conditions. Here, we provide intestinal flora changes of CKD patients undertook different hemodialysis therapy. Methods: From 2017 to 2019, a total of 166 patients from Guangzhou Red Cross Hospital were recruited and divided into four groups with 17 cases in healthy control group, 47 cases in CKD non-dialysis group, 49 cases in HD group, and 53 cases in PD group. Intestinal flora genome 16S rDNA sequencing and further bio-informatic analysis were performed. Results: Decreased diversity and altered communities of intestinal flora in PD patients, in which microbial diversity was positive correlated with the albumin level were observed. A total of 20 intestinal flora phyla were detected in 166 fecal samples, divided into 3 dominant intestinal types including Bacteroides-dominant gut type, Firmicutes-dominant type and Proteobacteria-dominant gut type. Further analyses found 198 genera, the abundance of 86 genera were significantly different. Butyrate-producing taxa as Faecalibacterium in genera level and Bifidobacteriaceae and Prevotellaceae in family level were dominant genus in CT, CKD, and HD groups, while urease containing-, indole- and p-cresol-forming taxa as Escherichia in genera and Enterobacteriaceae, Enterococcaceae in family level was dominated genus in PD group. Number of differential expressed genes in KEGG enrichment pathways were significantly different in PD group in carbohydrate metabolism, amino acid metabolism, energy metabolism, translation, and membrane transport. Conclusion: Our results suggest peritoneal dialysis therapy could result in reduced diversity and altered microbial communities, with reduced probiotic butyrate-producing taxa and increased urease containing-, indole- and p-cresol-forming taxa. The disordered intestinal flora can seriously affect the nutrition level in CKD patients with PD therapy.

1 November 2021 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
YHYanhuan He
Yanhuan He
YLYongxin Lu
Yongxin Lu
SYShenglin Yang
Shenglin Yang
YLYumin Li
Yumin Li
YYYaya Yang
Yaya Yang
MLMin Liang
Min Liang

2 June 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
YLYan Liu
Yan Liu
XXXiao Xiao
Xiao Xiao
DQDan-Ping Qin
Dan-Ping Qin
RTRong-Shao Tan
Rong-Shao Tan
XZXiao-Shi Zhong
Xiao-Shi Zhong
YZYuan-Yuan Zheng
Yuan-Yuan Zheng
Many long-term maintenance hemodialysis patients have symptoms of protein-energy wasting caused by malnutrition. Each session of hemodialysis removes about 10 to 12 g of amino acids and 200 to 480 kcal of energy. Patients receiving hemodialysis for chronic kidney disease may be undernourished for energy, protein consumption, or both. Non-diabetic hemodialysis patients were randomized to three treatment groups: oral supplementation, oral supplementation plus high-concentration glucose solution (250 mL containing 50% glucose) and these two interventions plus 8.5% amino acids solution. The post-treatment energy status of the glucose group was significantly higher than its baseline level, whereas the control group’s status was significantly lower. The glucose group had significantly higher concentrations of asparagine, glutamine, glycine, alanine, and lysine after treatment. All treatment groups had significantly increased hemoglobin levels but significantly decreased transferrin levels after treatment compared to baseline. After treatment, the amino acid group had significantly higher albumin level compared to the glucose group (p = 0.001) and significantly higher prealbumin level compared to the control group (p = 0.017). In conclusion, long-term intervention with high-concentration glucose solution at each hemodialysis session is a simple and cheap method that replenished energy stores lost during hemodialysis of non-diabetic patients.

4 April 2022 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
JHJianguang Hu
Jianguang Hu
XZXiaoshi Zhong
Xiaoshi Zhong
YLYan Liu
Yan Liu
JYJing Yan
Jing Yan
DZDaoyuan Zhou
Daoyuan Zhou
YLYun Liu
Yun Liu
Background: Different dialysis treatments may affect the composition and structure of the intestinal flora of dialysis-treated chronic kidney disease (CKD) patients. This study aimed to analyze the correlations between the different flora and the nutritional indexes and further explore the potential metabolic pathways in patients with CKD in end-stage renal disease (ESRD).Methods: Altogether, 102 patients with ESRD were recruited and categorized into the hemodialysis (HD) group (N = 49) and the peritoneal dialysis (PD) group (N = 53). Their biochemical indexes, anthropometric indicators, and inflammatory markers were determined. The total genomic DNA was extracted for 16S ribosomal DNA sequencing. Furthermore, bioinformatics analysis was employed for functional analysis.Results: Anthropometric indicators, including handgrip strength, mid-upper arm circumference, mid-upper arm muscle circumference, and body mass index, in the HD and PD groups showed a positive correlation with butyric acid-producing bacteria (RosellaandPhascolarctobacterium) and a negative correlation with conditional pathogens (Escherichiaspp.). Meanwhile, the inflammatory markers, including high-sensitivity C-reactive protein and interleukin-6, were significantly higher in the PD-protein–energy wasting (PEW) group than in the PD-non-protein–energy wasting (NPEW) group; although they showed an increasing trend in the HD-PEW group, no significant difference was noted.Rosellawas considerably scarce in the HD-PEW group than in the HD-NPEW group, whereasEscherichiawas substantially more abundant in the PD-PEW group than in the PD-NPEW group. Compared with the HD group, the essential amino acid synthesis pathway, amino acid metabolism-related enzyme pathways, and aminoacyl-transfer RNA biosynthesis pathways were weakened in the PD group. Most carbohydrate metabolic pathways were weakened, although the tricarboxylic acid cycle was slightly enhanced. Concurrently, the fatty acid metabolism was enhanced, whereas fatty acid synthesis was weakened; the metabolic pathways of B vitamins were also weakened. These potential metabolic pathways of the various compounds released by intestinal flora showed a significant correlation with blood biochemical indexes, anthropometric indicators, and inflammatory markers.Conclusion: In patients with ESRD, different dialysis treatments affected the abundance of butyric acid-producing bacteria (RosellaandPhascolarctobacterium) and conditional pathogens (Escherichiaspp.). Butyric acid-producing bacteria showed a positive correlation with PEW and showed a negative correlation withEscherichia. Improving the intestinal diversity and increasing the amount of butyric acid-producing bacteria, such asBlautella, Faecococcus, andPhascolarctobacterium, are potential therapeutic approaches to enhance protein–energy consumption in patients with ESRD.

10 October 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
YLYuzhuo Li
Yuzhuo Li
YLYun Liu
Yun Liu
RTRongshao Tan
Rongshao Tan
YLYan Liu
Yan Liu
The role of flavonoids in regulating the synthesis and function of skeletal muscles is increasingly recognized. However, randomized controlled trials have yielded inconsistent results on the influence of flavonoids on human muscular parameters. Therefore, we performed a meta-analysis to evaluate the possible effects of flavonoids on sarcopenia-related parameters in middle-aged and elderly people. Eligible literature and randomized controlled trials reports have been extensively searched from PubMed, Cochrane Library, Web of Science, and EMBASE databases until April 2022. A total of 20 articles involving 796 participants were available for the meta-analysis. There were significant benefits for participants in appendicular muscle mass gain (SMD = 0.29; 95% CI: 0.07, 0.52; P = 0.01) and 6-min walk distance (SMD = 0.37; 95% CI: 0.01, 0.73; P = 0.05). A subgroup analysis indicated that flavonoid significantly improves appendicular muscle mass (SMD = 0.50; 95% CI: 0.21, 0.80; P < 0.01) and Timed-Up and Go test (SMD = −0.47; 95% CI: −0.85, −0.09; P = 0.02) in Sarcopenia population. Our results provide insight into the effects of flavonoids on skeletal muscle mass and gait speed for those without exercise. However, there was no significant improvement in the subjects' muscle strength.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=334383, identifier: CRD42022334383.

1 November 2021 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
PDF file
YLYun Liu
Yun Liu
LWLiangtao Wang
Liangtao Wang
SLShuting Li
Shuting Li
SXShilin Xu
Shilin Xu
DZDaoyuan Zhou
Daoyuan Zhou
YLYan Liu
Yan Liu